Rare Blood Disorders
A set of illnesses known as rare blood disorders often afflict fewer than 1 in 2000 people, representing a tiny fraction of the population. The production, performance, or lifetime of blood cells, including red blood cells, white blood cells, and platelets, can be impacted by several hereditary or acquired illnesses.
Examples of rare blood conditions include:
1. A hereditary illness called haemophilia weakens the blood's capacity to clot, which causes protracted bleeding episodes.
2. A uncommon condition known as aplastic anaemia occurs when the bone marrow is unable to make enough new blood cells.
3. Hemolytic anaemia and associated difficulties are brought on by the unusual acquired condition known as paroxysmal nocturnal hemoglobinuria (PNH), in which the body's immune system assaults red blood cells.
4. A uncommon condition called thrombotic thrombocytopenic purpura (TTP) causes blood clots to develop in tiny blood capillaries all over the body, which lowers platelet counts and damages organs.
5. Hereditary spherocytosis is a hereditary condition that results in spherical red blood cells as opposed to disc-shaped ones, which causes anaemia, jaundice, and an enlarged spleen.
- Diagnosis and Management of Rare Anemias
- Rare Coagulation Factor Deficiencies: Diagnosis and Treatment
- Emerging Therapies for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Related Conference of Rare Blood Disorders
Rare Blood Disorders Conference Speakers
Recommended Sessions
- Anemia
- Biomarkers in Hematology
- Bleeding Disorders
- Clinical and Experimental Hematology
- Coagulopathies
- Gene and Cell Therapies for Blood Disorders
- Hematologic Malignancies
- Hematology and neurological disorders
- Hematology in COVID-19 patients
- Hematology in Pediatrics
- Hematology-oncology
- Hematopoietic Stem Cell Transplantation
- Hemostasis
- HIV/AIDS
- Immunohematology
- Immunotherapy for Blood Disorders
- Leukemia
- Myeloma
- Rare Blood Disorders
- Thalassemia
- Thrombosis and Hemostasis
Related Journals
Are you interested in
- Bleeding Disorders in Women - Blood Disorders 2024 (Ireland)
- Digital Health and Artificial Intelligence (AI) in Hematology - Blood Disorders 2024 (Ireland)
- Hematologic Gene Editing and Gene Therapies - Blood Disorders 2024 (Ireland)
- Hematology and Stem Cell Research - Blood Disorders 2024 (Ireland)
- Hematopoietic Stem Cell Transplantation - Blood Disorders 2024 (Ireland)
- Hemoglobinopathies and Sickle Cell Disease - Blood Disorders 2024 (Ireland)
- Hemophilia Management and Research - Blood Disorders 2024 (Ireland)
- Hemostasis and Thrombosis - Blood Disorders 2024 (Ireland)
- Immunotherapy and Hematology - Blood Disorders 2024 (Ireland)
- Leukemia and Lymphoma - Blood Disorders 2024 (Ireland)
- Medicine in Hematology - Blood Disorders 2024 (Ireland)
- Molecular Hematology - Blood Disorders 2024 (Ireland)
- Myelodysplastic Syndromes (MDS) and Bone Marrow Failure - Blood Disorders 2024 (Ireland)
- Next-Generation Diagnostics and Imaging - Blood Disorders 2024 (Ireland)
- Novel Therapies for Blood Cancers - Blood Disorders 2024 (Ireland)
- Pediatric Hematology - Blood Disorders 2024 (Ireland)
- Platelet Disorders - Blood Disorders 2024 (Ireland)
- Sickle Cell Disease (SCD) - Blood Disorders 2024 (Ireland)
- Thalassemia Management - Blood Disorders 2024 (Ireland)
- Transfusion Medicine and Blood Banking - Blood Disorders 2024 (Ireland)